Article

Approaches to establish thresholds for major food allergens and for gluten in food.

U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, 5100 Paint Branch Parkway, College Park, Maryland 20740-3835, USA.
Journal of food protection (Impact Factor: 1.8). 05/2008; 71(5):1043-88.
Source: PubMed
Download full-text

Full-text

Available from: Robert Buchanan, Jul 01, 2015
0 Followers
 · 
162 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In 2011, an expert panel was assembled to establish appropriate Reference Doses for allergenic food residues as a part of the VITAL (Voluntary Incidental Trace Allergen Labeling) program of The Allergen Bureau of Australia & New Zealand (ABA). These Reference Doses would guide advisory labeling decisions for use on food labels. Individual NOAELs and LOAELs were obtained from clinical challenges of food-allergic subjects. Statistical dose-distribution models (log-normal, log–logistic, Weibull) were applied to the individual NOAELs and LOAELs for each allergenic food. The Reference Doses, in terms of mg of total protein from the allergenic food, were based upon either the ED01 (for peanut, cow’s milk), the 95% lower confidence interval of the ED05 (for wheat, soybean, cashew, shrimp, sesame seed, mustard, and lupine), or both (egg, hazelnut) using all appropriate statistical dose-distribution models. Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein. Reference Doses were not established for fish or celery due to poor model fits with existing data. Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects.
    Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 01/2014; 63:9–17. DOI:10.1016/j.fct.2013.10.032 · 2.61 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Most of the recent studies suggest that oats are well tolerated by celiac disease (CD) patients. However, it is still possible that different oat cultivars may display different biological properties relevant for CD pathogenesis. We aimed to investigate biological and immunological properties of two oat varieties, Avena genziana and Avena potenza, in relation to their safety for CD patients. Phosphorylation of extracellular signal-regulated kinase (ERK) and trans-epithelial electrical resistance (TEER) were evaluated in CaCo-2 cells treated with peptic-tryptic (PT) digests from the two oats and from gliadin (PTG). With the same PT-digests, duodenal biopsies from 22 CD patients were treated in vitro for 24 h and density of CD25+ cells in lamina propria and of intraepithelial CD3+ T cells was measured, as well as crypt cell proliferation and epithelial expression of interleukin 15. Finally, interferon γ (IFN-γ) production was measured as evidence of gliadin-specific T-cell activation by PT-digests. In contrast to PTG, oats PT-digests were not able to induce significant increase in ERK phosphorylation and decrease in TEER in CaCo-2 cells. In the organ culture system, oats PT-digests, unlike PTG, did not induce significant increase in crypt enterocyte proliferation, increase in interleukin 15 expression or in lamina propria CD25+ cells. Nevertheless Avena potenza increased intraepithelial T-cell density, while Avena genziana-induced IFN-γ production in 3/8 CD intestinal T cell lines. Our data show that Avena genziana and Avena potenza do not display in vitro activities related to CD pathogenesis. Some T-cell reactivity could be below the threshold for clinical relevance.
    Scandinavian Journal of Gastroenterology 08/2011; 46(10):1194-205. DOI:10.3109/00365521.2011.603159 · 2.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: An overview is given of sensitization and allergic reaction on food, along with minimal eliciting doses for selected allergens (milk, egg, peanut), followed by the legislative situation in the European Community, the USA, Canada, Australia/New Zealand and Japan. The main focus of the paper discusses methods for food allergen determination (chromatography, DNA-based, antibody-based) and their limitations. Special emphasis is given on antibody-based systems, which are at the moment the most advanced and validated methods available. Examples are given of the current status of standardization for egg, milk, nuts, prolamins, glutelins and for clinical validated reference samples from the EU project EuroPrevall. Recommendations for ongoing activities are also included. KeywordsAllergen-ELISA-Standardization-Calibrant-Reference materials
    Accreditation and Quality Assurance 04/2009; 15(4):207-216. DOI:10.1007/s00769-009-0592-x · 1.05 Impact Factor